Health

HE A LTH • Winter 2019 5 MCPHS ranks 3rd in payoff for graduates MCPHS University doesn't have the prestige or name recognition of schools like Stanford, MIT and Harvard University, but a new study gives it bragging rights over those and other schools in an important area: better long-term payoff for graduates. A Georgetown University Center on Education and the Workforce ranking places MCPHS, which is based in Boston and has a downtown Worcester campus, third nationally at 30- and 40-year payoff — which Georgetown measures as net present value, a mea- sure of costs and future earnings. The net present value for MCPHS graduates at 30 years is $1.8 million and at 40 years is $2.4 million. Only two other schools, both also with pharmacy programs, rated higher: Albany College of Pharmacy & Health Sciences in New York and St. Louis College of Pharmacy in Missouri. Addiction treatment firm buys Marlborough space Oxana Antonevic, the president of New Horizons Medical, has purchased a f lex-space industrial condominium in Marlborough for $469,000. New Horizons Medical has locations in Brookline, Framingham, Quincy and Lynn and specializes in suboxone treatment, which is used to treat addi- tion, like opioids. Two years after spending $1.7B, Hologic sells subsidiary for $205M Marlborough medical technology company Hologic has agreed to sell its medical aesthetics unit Cynosure for $205 million to New York private equi- ty company Clayton, Dubilier & Rice. Selling Cynosure will enable Hologic to focus on its medical products for women, said Steve MacMillan, Hologic's chairman, president and CEO, in a statement. Hologic acquired Cynosure for $1.65 billion in February 2017, and MacMillan said the unit significantly underperformed expectations. Approximately 825 employees with Cynosure, which is based in Westford, will transfer with Cynosure sale. Millis marijuana retailer begins medical sales Cannabis grower and retailer CommCan, Inc. began medical sales at its Millis dispensary in November, more than two weeks after it began recreational sales. The Millis store is the second retail location for CommCan, in addition to its medical- only Southborough location. Holden Hearing Aid Center, Inc. 695 Main Street, Holden MA 01520 Phone: (508) 829-5566 www.HoldenHearingAid.com Let our Center help you HEAR better! Matthew Moreno, Au.D. Doctor of Audiology Swim Plugs We offer comprehensive hearing care services including complete hearing evaluations, hearing loss rehabilitation, education and counseling. Amplified Phones Hearing Aids Batteries & Accessories Assisted Listening Devices Hearing Evaluations Wax Removal Hearing Protection Musician's Ear Plugs Biostage applies to FDA for throat implant Holliston bioengineering firm Biostage has applied to the U.S. Food and Drug Administration for a new esophageal implant, following what Biostage says was pre-clinical and clinical evidence supporting first-in- human clinical trials. The proposed new product, the Cellspan esophageal implant, attaches a biocompatible scaffold with a patient's own cells to create an esophageal implant to potentially be used to treat pediatric esophageal atresia and other conditions impacting the esophagus. Seven Hills to acquire $3.2M Worcester nonprofit Family Services of Central Massachusetts will become an affiliate of Worcester nonprofit Seven Hills Foundation in January. Founded more than 130 years ago, Family Services has $3.2 million in annual income. It offers individual, child and family counseling, employee assistance, home care, community mediation, senior volunteer and com- panion opportunities. With its headquarters in Worcester, Seven Hills offers program sites at 160 locations in Massachusetts and Rhode Island employing nearly 4,000 profes- sionals. Seven Hills is the region's larg- est nonprofit, with $220 million in annual income, servicing more than 45,000 though its 13 affiliates. Definitive among fastest- growing tech firms Definitive Healthcare, a Framingham health information services company, is the 267th fastest- growing technology firm in the country, according to a new list by the international professional services firm Deloitte. Definitive Healthcare grew by 413% in the past year, placing it as the only Central Massachusetts firm on the Deloitte Technology Fast 500 list and one of 36 from Massachusetts. Boston alone accounted for 15 firms on the list, and Cambridge had another 12, including second overall with Sarepta Therapeutics, a medical research and pharmaceutical firm. Definitive Healthcare, which serves pharmaceutical and medical device firms, care providers and others, has been growing fast enough to be finding itself on such lists before. The company made Inc. 5000's list of the fastest-growing private companies this summer, landing 1,020th nationally. It landed 184th on Deloitte's list last year, when its year- to-year growth was 528%, and 152nd in 2017 when it grew 707%. Littleton firm to provide Taiwan cancer treatment Mevion Medical Systems, a Littleton firm providing proton therapy, will bring its services to Taiwan. Mevion's proton therapy, a type of radiation therapy for cancer patients, will be performed under a collabora- tion with Chung Shan Medical University Hospital in Taichung City, Taiwan. A third member of the agree- ment is Marlborugh's ASYS Corp., a biomedical healthcare engineering, sales and services firm. Chung Shan is the leading health- care provider in the central region of Taiwan, and has been proactively exploring advanced therapies. Proton therapy, according to Mevion, is a more precise therapeutic radiation to tumors and less damaging to nearby organs. Fallon posts $20.2M operating loss Fallon Health had an operating loss of $20.2 million in the third quarter, the insurer reported in November, extending a somewhat challenging year for the Worcester company. Fallon's third-quarter loss came on revenue of $429 million. Revenue so far this year has been f lat compared to the same period in 2018 at $1.2 billion. Net results in the third quarter were improved by investment and other income of $15.8 million. Fallon's membership was down 2.4% from a high of 271,369 reached at the end of 2018. Year-to-date through the end of September, Fallon has reported an operating loss of $17.5 million. Two other major health insurers in the state, Blue Cross Blue Shield of Massachusetts and Harvard Pilgrim Health Care, both reported profitable third quarters. Boston-based Blue Cross Blue Shield — the state's largest health insurer with 2.9 million members — reported oper- ating income of $33.7 million on reve- nue of $2.1 billion. Harvard Pilgrim, of Wellesley, had operating income of $12.5 million on revenue of $719.5 million, with mem- bership growing slightly at more than 1.1 million. Mevion signed a care agreement with Chung Shan Medical University Hospital. H

• Cover